Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pigment epithelium-derived factor enhances tumor response to radiation through vasculature normalization in allografted lung cancer in mice

Subjects

Abstract

This study aimed to explore the potential therapeutic effects of the combination of pigment epithelium-derived factor (PEDF) and radiation on lung cancer. The Lewis lung cancer (LLC) allografts in nude mice were treated with radiation, PEDF and PEDF combined with radiation. The morphologic changes of tumor vasculature and the hypoxic fraction of tumor tissues were evaluated. Significant inhibition of tumor growth was observed when radiation was applied between the 3rd and 7th day (the vasculature normalization window) after the initiation of PEDF treatment. During the vasculature normalization window, the tumor blood vessels in PEDF-treated mice were less tortuous and more uniform than those in the LLC allograft tumor treated with phosphate-buffered saline. Meanwhile, the thickness of the basement membrane was remarkably reduced and pericyte coverage was significantly increased with the PEDF treatment. We also found that tumor hypoxic fraction decreased during the 3rd to the 7th day after PEDF treatment, suggesting improved intratumoral oxygenation. Taken together, our results show that PEDF improved the effects of radiation therapy on LLC allografts by inducing a vascular normalization window from the 3rd to the 7th day after PEDF treatment. Our findings provide a basis for treating lung cancer with the combination of PEDF and radiation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10–29.

    PubMed  Google Scholar 

  2. Steele FR, Chader GJ, Johnson LV, Tombran-Tink J . Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA 1993; 90: 1526–1530.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Tombran-Tink J, Johnson LV . Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 1989; 30: 1700–1707.

    CAS  PubMed  Google Scholar 

  4. Cao W, Tombran-Tink J, Elias R, Sezate S, Mrazek D, McGinnis JF . In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2001; 42: 1646–1652.

    CAS  PubMed  Google Scholar 

  5. Tombran-Tink J, Chader GG, Johnson LV . PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991; 53: 411–414.

    Article  CAS  PubMed  Google Scholar 

  6. Ramirez-Castillejo C, Sanchez-Sanchez F, Andreu-Agullo C, Ferron SR, Aroca-Aguilar JD, Sanchez P et al. Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat Neurosci 2006; 9: 331–339.

    Article  CAS  PubMed  Google Scholar 

  7. Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX . Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 2006; 20: 323–325.

    Article  CAS  PubMed  Google Scholar 

  8. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285: 245–248.

    Article  CAS  PubMed  Google Scholar 

  9. Stellmach V, Crawford SE, Zhou W, Bouck N . Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci USA 2001; 98: 2593–2597.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ek ET, Dass CR, Choong PF . PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends Mol Med 2006; 12: 497–502.

    Article  CAS  PubMed  Google Scholar 

  11. Wang L, Schmitz V, Perez-Mediavilla A, Izal I, Prieto J, Qian C . Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor. Mol Ther 2003; 8: 72–79.

    Article  CAS  PubMed  Google Scholar 

  12. Chen Q, Cheng P, Song N, Yin T, He H, Yang L et al. Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model. Oncol Lett 2012; 4: 413–418.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Chandolu V, Dass CR . Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particular. J Biomed Biotechnol 2012; 2012: 740295.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Broadhead ML, Dass CR, Choong PF . Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model. Br J Cancer 2011; 105: 1503–1511.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. He SS, Shi HS, Yin T, Li YX, Luo ST, Wu QJ et al. AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits Lewis lung carcinoma growth in mice. Oncol Rep 2012; 27: 1142–1148.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Yang J, Chen S, Huang X, Han J, Wang Q, Shi D et al. Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesis. Cancer Biol Ther 2010; 9: 967–974.

    Article  CAS  PubMed  Google Scholar 

  17. Murray AR, Ma JX . PEDF as a treatment for cervical cancer. Cancer Biol Ther 2010; 9: 975–977.

    Article  CAS  PubMed  Google Scholar 

  18. Peng F, Xu Z, Wang J, Chen Y, Li Q, Zuo Y et al. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models. PLoS One 2012; 7: e34646.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Rosenberger C, Rosen S, Paliege A, Heyman SN . Pimonidazole adduct immunohistochemistry in the rat kidney: detection of tissue hypoxia. Methods Mol Biol 2009; 466: 161–174.

    Article  CAS  PubMed  Google Scholar 

  20. Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM . Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 2003; 163: 1801–1815.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ozerdem U, Grako KA, Dahlin-Huppe K, Monosov E, Stallcup WB . NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 2001; 222: 218–227.

    Article  CAS  PubMed  Google Scholar 

  22. Folkman J . Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 1972; 175: 409–416.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Carmeliet P, Jain RK . Angiogenesis in cancer and other diseases. Nature 2000; 407: 249–257.

    Article  CAS  PubMed  Google Scholar 

  24. Sato Y . Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy. Cancer Sci 2011; 102: 1253–1256.

    Article  CAS  PubMed  Google Scholar 

  25. Carmeliet P, Jain RK . Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 2011; 10: 417–427.

    Article  CAS  PubMed  Google Scholar 

  26. Jain RK . Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005; 307: 58–62.

    Article  CAS  PubMed  Google Scholar 

  27. Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004; 6: 553–563.

    CAS  PubMed  Google Scholar 

  28. Plate KH, Scholz A, Dumont DJ . Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited. Acta Neuropathol 2012; 124: 763–775.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Manalo KB, Choong PF, Dass CR . Pigment epithelium-derived factor as an impending therapeutic agent against vascular epithelial growth factor-driven tumor-angiogenesis. Mol Carcinogen 2011; 50: 67–72.

    Article  CAS  Google Scholar 

  30. Xu Z, Fang S, Zuo Y, Zhang Y, Cheng R, Wang Q et al. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis. Cancer Sci 2011; 102: 1789–1798.

    Article  CAS  PubMed  Google Scholar 

  31. Demestre M, Terzi MY, Mautner V, Vajkoczy P, Kurtz A, Pina AL . Effects of pigment epithelium derived factor (PEDF) on malignant peripheral nerve sheath tumours (MPNSTs). J Neurooncol 2013; 115: 391–399.

    Article  CAS  PubMed  Google Scholar 

  32. Mejias M, Coch L, Berzigotti A, Garcia-Pras E, Gallego J, Bosch J et al. Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats. Gut 2014. (doi:10.1136/gutjnl-2014-307138).

    Article  PubMed  Google Scholar 

  33. Li N, Zheng D, Wei X, Jin Z, Zhang C, Li K . Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model. J Cancer Res Clin Oncol 2012; 138: 1131–1144.

    Article  CAS  PubMed  Google Scholar 

  34. McGee MC, Hamner JB, Williams RF, Rosati SF, Sims TL, Ng CY et al. Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation. Int J Radiat Oncol Biol Phys 2010; 76: 1537–1545.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 2011; 91: 1071–1121.

    Article  CAS  PubMed  Google Scholar 

  36. Konson A, Pradeep S, D'Acunto CW, Seger R . Pigment epithelium-derived factor and its phosphomimetic mutant induce JNK-dependent apoptosis and p38-mediated migration arrest. J Biol Chem 2011; 286: 3540–3551.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (30872974, 81172116 and 81201736), the Science and Technology Planning Project of Guangdong Province, China (2009B030801154) and the Plan of Financial Support for the R&D of Dongguan’s Higher Education, Scientific Research and Medical Institutions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Chen.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, Z., Dong, Y., Peng, F. et al. Pigment epithelium-derived factor enhances tumor response to radiation through vasculature normalization in allografted lung cancer in mice. Cancer Gene Ther 22, 181–187 (2015). https://doi.org/10.1038/cgt.2014.79

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2014.79

This article is cited by

Search

Quick links